A systems methodology to assess the risk of tumor relapse in melanoma by the profiling of plasma extracellular vesicles (MelEVIR)

Third Party Funds Group - Sub project


Acronym: MelEVIR

Start date : 01.04.2016

End date : 31.03.2019

Extension date: 31.05.2020